PMID- 32867602 OWN - NLM STAT- MEDLINE DCOM- 20210903 LR - 20210903 IS - 1557-8534 (Electronic) IS - 1547-3287 (Linking) VI - 29 IP - 21 DP - 2020 Nov 1 TI - Effect of Human Umbilical Cord Mesenchymal Stem Cells Transfected with HGF on TGF-beta1/Smad Signaling Pathway in Carbon Tetrachloride-Induced Liver Fibrosis Rats. PG - 1395-1406 LID - 10.1089/scd.2020.0060 [doi] AB - The research on human umbilical cord-derived mesenchymal stem cells (hUCMSCs) suggests promising therapeutic strategy for ameliorating liver fibrosis and it can be an effective alternative method of orthotopic liver transplantation. Hepatocyte growth factor (HGF) is the most basic cytokine involved in the inhibition of liver fibrosis and promotion of hepatocyte proliferation and regeneration. The objective of this study was to determine the possible mechanism about how the microencapsulated hUCMSCs made by alginate-poly-lysine-alginate (A-P-A) transfected with HGF could ameliorate liver fibrosis through the TGF-beta1/Smad signaling pathway. The microencapsulated cells were divided into four groups: hUCMSC (microcapsules of hUCMSCs), HGF (microcapsules of HGF+hUCMSCs), LV5-NC (microcapsules of LV5-NC, an rLV-EF1a-EGFP+Puro control lentiviral vector+hUCMSCs), and empty microcapsule (microcapsules without any hUCMSCs), and then transplanted by intraperitoneal injection into carbon tetrachloride (CCl(4))-induced liver fibrosis rats, respectively. The results showed that the fibrosis in the hUCMSC, LV5-NC, and HGF groups was significantly alleviated. Moreover, the messenger RNA (mRNA) and protein levels of collagen I, collagen III, alpha-SMA, TGF-beta1, Smad2, and Smad3 were significantly decreased compared with the empty microcapsule group and these indices in HGF group were more decreased compared with hUCMSC and LV5-NC groups. This study indicated that microencapsulated hUCMSCs transfected with HGF could effectively improve CCl(4)-induced rat liver fibrosis and the possible mechanism was closely related to the inhibition of TGF-beta1/Smad signaling pathway. FAU - Yin, Fei AU - Yin F AD - Department of Histology and Embryology, Basic Medical College of Jilin University, Changchun, China. FAU - Wang, Wen-Ying AU - Wang WY AD - Department of Histology and Embryology, Basic Medical College of Jilin University, Changchun, China. FAU - Mao, Li-Cui AU - Mao LC AD - Department of Histology and Embryology, Basic Medical College of Jilin University, Changchun, China. FAU - Cai, Qi-Qi AU - Cai QQ AD - Department of Histology and Embryology, Basic Medical College of Jilin University, Changchun, China. FAU - Jiang, Wen-Hua AU - Jiang WH AD - Department of Histology and Embryology, Basic Medical College of Jilin University, Changchun, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200924 PL - United States TA - Stem Cells Dev JT - Stem cells and development JID - 101197107 RN - 0 (Acta2 protein, rat) RN - 0 (Actins) RN - 0 (Smad Proteins) RN - 0 (Transforming Growth Factor beta1) RN - 67256-21-7 (Hepatocyte Growth Factor) RN - 9007-34-5 (Collagen) RN - CL2T97X0V0 (Carbon Tetrachloride) SB - IM MH - Actins/metabolism MH - Animals MH - Carbon Tetrachloride MH - Collagen/metabolism MH - Hepatocyte Growth Factor/*metabolism MH - Humans MH - Infant, Newborn MH - Liver Cirrhosis/*chemically induced/*therapy MH - Male MH - Mesenchymal Stem Cells/*cytology/metabolism MH - Rats, Wistar MH - Signal Transduction MH - Smad Proteins/*metabolism MH - *Transfection MH - Transforming Growth Factor beta1/*metabolism MH - Umbilical Cord/*cytology OTO - NOTNLM OT - A-P-A microcapsule OT - TGF-beta1/Smad signaling pathway OT - cell therapy OT - hepatocyte growth factor OT - human umbilical cord mesenchymal stem cells OT - liver fibrosis EDAT- 2020/09/02 06:00 MHDA- 2021/09/04 06:00 CRDT- 2020/09/02 06:00 PHST- 2020/09/02 06:00 [pubmed] PHST- 2021/09/04 06:00 [medline] PHST- 2020/09/02 06:00 [entrez] AID - 10.1089/scd.2020.0060 [doi] PST - ppublish SO - Stem Cells Dev. 2020 Nov 1;29(21):1395-1406. doi: 10.1089/scd.2020.0060. Epub 2020 Sep 24.